Zhang Z, He F, Li W, Liu B, Deng C, Qin X (2025) Material-driven therapeutics: Functional nanomaterial design paradigms revolutionizing osteosarcoma treatment. J Funct Biomater 16(6):213. doi: 10.3390/jfb16060213 PMID: 40558899
Objective: To examine nanomaterial applications in Osteosarcoma (OS) therapy through a materials science lens, analyzing mechanism specific interventions. The analysis establishes a framework for developing next-generation nanotherapeutic platforms to address persistent limitations in OS management.
Summary: Phytic acid (PA)-functionalized nanoparticles (e.g., MnO2-PA) exploit high hydroxyapatite affinity for osseous tumor accumulation. Bone-specific targeting is exemplified by saporin-boronated nanotherapeutics, which achieve ribosomal inactivation through hydroxyapatite binding, offering a targeted approach for bone malignancies.
Usage: Saporin delivery in an orthotopic model significantly inhibited Osteosarcoma. GPSP (100 μg/kg saporin + 133.3 μg/kg GP + 140 μg/kg PASP) was intravenously injected with a Saporin concentration of 100 µg/kg. In a Bone-Metastatic Breast Cancer disease model, GPSP (150 μg/kg saporin + 200 μg/kg GP + 210 μg/kg PASP) was injected with a Saporin concentration of 150 µg/kg.
Related Products: Saporin (Cat. #PR-01)